1
|
Zhou XH: Primary squamous cell carcinoma
of the thyroid. Eur J Surg Oncol. 28:42–45. 2002. View Article : Google Scholar : PubMed/NCBI
|
2
|
Syed MI, Stewart M, Syed S, Dahill S,
Adams C, McLellan DR and Clark LJ: Squamous cell carcinoma of the
thyroid gland: Primary or secondary disease? J Laryngol Otol.
125:3–9. 2011. View Article : Google Scholar : PubMed/NCBI
|
3
|
Lam KY, Lo CY and Liu MC: Primary squamous
cell carcinoma of the thyroid gland: An entity with aggressive
clinical behaviour and distinctive cytokeratin expression profiles.
Histopathology. 39:279–286. 2001. View Article : Google Scholar : PubMed/NCBI
|
4
|
Kebebew E, Greenspan FS, Clark OH, Woeber
KA and McMillan A: Anaplastic thyroid carcinoma. Treatment outcome
and prognostic factors. Cancer. 103:1330–1335. 2005. View Article : Google Scholar : PubMed/NCBI
|
5
|
Zhang YX, Zhang B, Wu YH, Liu WS, Liu SY,
Gao L, Xu ZG and Tang PZ: Primary squamous cell carcinoma of the
thyroid: Retrospective analysis of 28 cases. Zhonghua Er Bi Yan Hou
Tou Jing Wai Ke Za Zhi. 48:143–147. 2013.(In Chinese). PubMed/NCBI
|
6
|
Abraham KP, Reddy V and Gattuso P:
Neoplasms metastatic to the heart: Review of 3314 consecutive
autopsies. Am J Cardiovasc Pathol. 3:195–198. 1990.PubMed/NCBI
|
7
|
Catford SR, Lee KT, Pace MD, Marasco SF,
Longano A and Topliss DJ: Cardiac metastasis from thyroid
carcinoma. Thyroid. 21:855–866. 2011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Hara K, Ohno M, Takenaga M, Tsuneyoshi H,
Takeuchi H, Kashida M, Yamaguchi T, Machii K, Furuta S and Tohda E:
Metastatic thyroid cancer to the right ventricle causing
obstruction of the right ventricular outflow tract and associated
with disseminated intravascular coagulopathy: A case report. J
Cardiogr. 16:765–767. 1986.(In Japanese). PubMed/NCBI
|
9
|
Madani A, Jozaghi Y, Tabah R, How J and
Mitmaker E: Rare metastases of well-differentiated thyroid cancers:
A systematic review. Ann Surg Oncol. 22:460–466. 2015. View Article : Google Scholar : PubMed/NCBI
|
10
|
Sallah S, Wan JY, Nguyen NP, Hanrahan LR
and Sigounas G: Disseminated intravascular coagulation in solid
tumors: Clinical and pathologic study. Thromb Haemost. 86:823–833.
2001.
|
11
|
Sutherland DE, Weitz IC and Liebman HA:
Thromboembolic complications of cancer: Epidemiology, pathogenesis,
diagnosis, and treatment. Am J Hematol. 72:43–52. 2003. View Article : Google Scholar : PubMed/NCBI
|
12
|
John T and Davis ID: Ventricular
metastasis resulting in disseminated intravascular coagulation.
World J Surg Oncol. 24:292005. View Article : Google Scholar
|
13
|
Feinstein DI: Disseminated intravascular
coagulation in patients with solid tumors. Oncology (Williston
Park). 29:96–102. 2015.PubMed/NCBI
|
14
|
Wells SA Jr, Robinson BG, Gagel RF, Dralle
H, Fagin JA, Santoro M, Baudin E, Elisei R, Jarzab B, Vasselli JR,
et al: Vandetanib in patients with locally advanced or metastatic
medullary thyroid cancer: A randomized, double-blind phase III
trial. J Clin Oncol. 30:134–141. 2012. View Article : Google Scholar : PubMed/NCBI
|
15
|
Brose MS, Nutting CM, Jarzab B, Elisei R,
Siena S, Bastholt L, de la Fouchardiere C, Pacini F, Paschke R,
Shong YK, et al: Sorafenib in radioactive iodine-refractory,
locally advanced or metastatic differentiated thyroid cancer: A
randomized, double-blind, phase 3 trial. Lancet. 384:319–328. 2014.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Schlumberger M, Tahara M, Wirth LJ,
Robinson B, Brose MS, Elisei R, Habra MA, Newbold K, Shah MH, Hoff
AO, et al: Lenvatinib versus placebo in radioiodine-refractory
thyroid cancer. N Engl J Med. 372:621–630. 2015. View Article : Google Scholar : PubMed/NCBI
|
17
|
Higashiyama T, Ito Y, Hirokawa M,
Fukushima M, Uruno T, Miya A, Matsuzuka F and Miyauchi A: Induction
chemotherapy with weekly paclitaxel administration for anaplastic
thyroid carcinoma. Thyroid. 20:7–14. 2010. View Article : Google Scholar : PubMed/NCBI
|
18
|
Onoda N, Sugitani I, Higashiyama T, Hara
H, Ito K, Kammori M, Sugino K, Suzuki S, Toda K, Yoshida A and
Miyauchi A: Concept and design of a nationwide prospective
feasibility/efficacy/safety study of weekly paclitaxel for patients
with pathologically confirmed anaplastic thyroid cancer
(ATCCJ-PTX-P2). BMC Cancer. 15:4752015. View Article : Google Scholar : PubMed/NCBI
|
19
|
Fraser RS, Muller NL, Colman N, et al:
Pulmonary neoplasmsDiagnosis of disease of the chest. 4th.
Philadelphia: W.B. Saunders Company; pp. 1405–1407. 1999
|
20
|
Bassiri AG, Haghighi B, Doyle RL, Berry GJ
and Rizk NW: Pulmonary tumor embolism. Am J Respir Crit Care Med.
155:2089–2095. 1997. View Article : Google Scholar : PubMed/NCBI
|
21
|
Chan CK, Hutcheon MA, Hyland RH, Smith GJ,
Patterson BJ and Matthay RA: Pulmonary tumor embolism: A critical
review of clinical, imaging, and hemodynamic features. J Thorac
Imaging. 2:4–14. 1987. View Article : Google Scholar : PubMed/NCBI
|
22
|
Roberts KE, Hamele-Bena D, Saqi A, Stein
CA and Cole RP: Pulmonary tumor embolism: A review of the
literature. Am J Med. 115:228–232. 2003. View Article : Google Scholar : PubMed/NCBI
|
23
|
Luo H, Tulpule S, Alam M, Patel R, Sen S
and Yousif A: A rare silent killer: Right atrial metastasis of
thyroid hürthle cell carcinoma. Case Rep Oncol. 8:233–237. 2015.
View Article : Google Scholar : PubMed/NCBI
|